Article Details

Aytu BioPharma Divests US Rights to Natesto(R) to Acerus Pharma

Retrieved on: 2021-04-01 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

Aytu BioPharma Divests US Rights to Natesto(R) to Acerus Pharma. View article details on hiswai:

Excerpt

ENGLEWOOD, CO / ACCESSWIRE / April 1, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU) a specialty pharmaceutical company focused on ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up